Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
about
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary RevascularizationIschaemic Stroke Following Percutaneous Transluminal Coronary Angioplasty (PTCA): A Rare Complication.The current cost of angina pectoris to the National Health Service in the UK.The first year of the Venlo percutaneous coronary intervention program: procedural and 6-month clinical outcomes.A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.
P2860
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@en
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@nl
type
label
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@en
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@nl
prefLabel
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@en
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@nl
P2093
P356
P1476
Evolution of percutaneous transluminal coronary angioplasty in Europe from 1992-1996.
@en
P2093
P304
P356
10.1053/EUHJ.2001.2737
P50
P577
2001-09-01T00:00:00Z